Mona Nemer · Chief Science Advisor, Innovation, Science and Economic Development Canada (ISED)
Bringing attention to OHA's Pre Budget Submission which includes the following:
Recommendation 1: Position Canada as a global leader in the health research industry by strengthening talent pipelines, sustaining funding, and leveraging diversity.
Recommendation 2: Bolster Canada’s competitiveness by accelerating health research commercialization through regulatory modernization, infrastructure investment, and federal-provincial partnerships.Read more
Vanessa Peart · Director, Innovation, Science and Economic Development Canada (ISED)
Lina Johnston · Senior Policy Analyst, Innovation, Science and Economic Development Canada (ISED)
Bringing attention to OHA's Pre Budget Submission which includes the following:
Recommendation 1: Position Canada as a global leader in the health research industry by strengthening talent pipelines, sustaining funding, and leveraging diversity.
Recommendation 2: Bolster Canada’s competitiveness by accelerating health research commercialization through regulatory modernization, infrastructure investment, and federal-provincial partnerships.Read more
Manuela Tomic · Senior Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
Bringing attention to OHA's Pre Budget Submission which includes the following:
Recommendation 1: Position Canada as a global leader in the health research industry by strengthening talent pipelines, sustaining funding, and leveraging diversity.
Recommendation 2: Bolster Canada’s competitiveness by accelerating health research commercialization through regulatory modernization, infrastructure investment, and federal-provincial partnerships.Read more
Bringing attention to OHA's Pre Budget Submission which includes the following:
Recommendation 1: Position Canada as a global leader in the health research industry by strengthening talent pipelines, sustaining funding, and leveraging diversity.
Recommendation 2: Bolster Canada’s competitiveness by accelerating health research commercialization through regulatory modernization, infrastructure investment, and federal-provincial partnerships.Read more
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026.
Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month.
Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means.
Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence.
PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.